Please login to the form below

Not currently logged in
Email:
Password:

UCB CEO elected to the Ministerial Industry Strategy Group

Jean-Christophe Tellier assumed the role of CEO on January 1
Jean-Christophe Tellier

UCB's new CEO Jean-Christophe Tellier has been elected to join the Ministerial Industry Strategy Group (MISG).

Tellier was elected by member of the European Medicines Group (EMG) and will act as group representative for the European pharma companies.

Commenting on the election, Tellier said: “The UK life sciences industry is one of the most successful at a global level and it is an important contributor to the country's economic prosperity.

“Therefore, I am pleased to be sharing some of UCB's experience as an inward R&D inward investor with the MISG, in an effort to shape a positive climate that incentivises innovation for the improvement of patient care.”

Tellier joined UCB in 2011 as an executive VP after serving as president of Ipsen, North America, and CEO of Novartis pharma France. He has 25 years of experience in the industry, aided by a medical background as a rheumatologist.

Tellier was named as UCB's next CEO early last year, but did not assume the role until January 1 of this year.

25th February 2015

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...